1. Treatment of arthritic disorders: non-acetylated salicylates vs other NSAIDs

   Newsletter Article 05 February 2013 Pages: 2 - 2

2. Hypersensitivity reactions to penicillin and other Β-lactam drugs

   Newsletter Article 05 February 2013 Pages: 2 - 3

3. Cardiovascular sequelae complicating interleukin 2 therapy

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. The effects of antirheumatic therapy on pregnancy and fertility

   Newsletter Article 05 February 2013 Pages: 3 - 4

5. Acenocoumarol

   Newsletter Article 05 February 2013 Pages: 4 - 4

6. Antidepressants

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Antidepressants, tricyclic overdose

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Anti-infectives

   Newsletter Article 05 February 2013 Pages: 4 - 5

9. Antimalarials

   Newsletter Article 05 February 2013 Pages: 5 - 5

10. Atenolol

    Newsletter Article 05 February 2013 Pages: 5 - 5

11. Benzodiazepines

    Newsletter Article 05 February 2013 Pages: 5 - 5

12. Benzodiazepine withdrawal

    Newsletter Article 05 February 2013 Pages: 5 - 5

13. Benzylpenicillin

    Newsletter Article 05 February 2013 Pages: 6 - 6

14. Bezafibrate

    Newsletter Article 05 February 2013 Pages: 6 - 6

15. Caffeine abuse

    Newsletter Article 05 February 2013 Pages: 6 - 6

16. Caffeine overdose

    Newsletter Article 05 February 2013 Pages: 6 - 6

17. Calcitonin

    Newsletter Article 05 February 2013 Pages: 6 - 6

18. Captopril/enalapril

    Newsletter Article 05 February 2013 Pages: 6 - 6

19. Carbamazepine/valproice acid

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Ciprofloxacin

    Newsletter Article 05 February 2013 Pages: 7 - 7

21. Cisplatin

    Newsletter Article 05 February 2013 Pages: 7 - 7

22. Cisplatin see Fluorouracil/cisplatin

    Newsletter Article 05 February 2013 Pages: 7 - 7

23. Corticotrophin-releasing hormone

    Newsletter Article 05 February 2013 Pages: 7 - 7

24. Cyclosporin

    Newsletter Article 05 February 2013 Pages: 7 - 7

25. Cyproterone

    Newsletter Article 05 February 2013 Pages: 7 - 7

26. Dothiepin

    Newsletter Article 05 February 2013 Pages: 7 - 8

27. Enalapril see Captopril/enalapril

    Newsletter Article 05 February 2013 Pages: 8 - 8

28. Erythromycin

    Newsletter Article 05 February 2013 Pages: 8 - 8

29. Erythropoietin

    Newsletter Article 05 February 2013 Pages: 8 - 8

30. Estrogen/progestogen

    Newsletter Article 05 February 2013 Pages: 8 - 8

31. Fluorouracil

    Newsletter Article 05 February 2013 Pages: 8 - 9

32. Fluorouracil/cisplatin

    Newsletter Article 05 February 2013 Pages: 9 - 9

33. Haematin

    Newsletter Article 05 February 2013 Pages: 9 - 9

34. Hydrocortisone see Prednisone/hydrocortisone

    Newsletter Article 05 February 2013 Pages: 9 - 9

35. Interleukin 2

    Newsletter Article 05 February 2013 Pages: 9 - 9

36. Magnesium sulfate overdose

    Newsletter Article 05 February 2013 Pages: 9 - 9

37. Methylprednisolone

    Newsletter Article 05 February 2013 Pages: 9 - 10

38. Minocycline

    Newsletter Article 05 February 2013 Pages: 10 - 10

39. Penicillamine

    Newsletter Article 05 February 2013 Pages: 10 - 10

40. Prednisone/hydrocortisone

    Newsletter Article 05 February 2013 Pages: 10 - 11

41. Progestogen see Estrogen/progestogen

    Newsletter Article 05 February 2013 Pages: 11 - 11

42. Propranolol

    Newsletter Article 05 February 2013 Pages: 11 - 11

43. Protamine sulfate

    Newsletter Article 05 February 2013 Pages: 11 - 11

44. Ranitidine see Theophylline interaction

    Newsletter Article 05 February 2013 Pages: 11 - 11

45. Streptomycin

    Newsletter Article 05 February 2013 Pages: 11 - 11

46. Theophylline interaction

    Newsletter Article 05 February 2013 Pages: 11 - 12

47. Thiazide diuretics

    Newsletter Article 05 February 2013 Pages: 12 - 12

48. Tiapride

    Newsletter Article 05 February 2013 Pages: 12 - 12

49. Vaccine, pertussis

    Newsletter Article 05 February 2013 Pages: 12 - 12

50. Valproic acid see Carbamazepine/valproic acid

    Newsletter Article 05 February 2013 Pages: 12 - 12